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ABSTRACT 
Congenital heart disease (CHD) is formed during intrauterine period but, 
as a rule, they are not hereditary. Hemophilia A belongs to the group of 
hereditary coagulopathies stipulated by deficiency of coagulation factor 
VIII and characterized by bleeding of hematoma like type. Combination 
of these two diseases is rather rare that requires cardiosurgeons’ 
apprehensive attitude. 
We present our experience in surgical treatment of a boy of 8 months old 
with Tetralogy of Fallot. Hemophilia A was found in preoperative 
examination. He was successfully operated with cardiac pulmonary bypass 
on the background of factor VII injection. 
Surgical treatment was successful without significant bleeding. Postoperative 
period was uneventful. For successful treatment of CHD with coagulation 
failure is very important timely diagnosis, that can be difficult due to the lack 
of specific symptoms in children. 
Surgical treatment is the method of choice in TOF. Timely and complete 
diagnosis of comorbidities allows to make it safe even in case of 
Hemophilia A. 
KEYWORDS 
congenital heart disease,  
tetralogy of Fallot,  
hemophilia A,  
surgical treatment,  
coagulopathy. 
Citation: Kulikova D. O., Pisklova Y. V., Buchnieva O. V., Piddubna I. M. (2019) Combination of 
Tetralogy of Fallot and Hemophilia in a Child: Case Report. World Science. 7(47), Vol.1. doi: 
10.31435/rsglobal_ws/31072019/6588 
Copyright: © 2019 Kulikova D. O., Pisklova Y. V., Buchnieva O. V., Piddubna I. M. This is an open-
access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and 
that the original publication in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms. 
 
Introduction. Congenital heart disease (CHD) is formed during intrauterine period but, as a 
rule, they are not hereditary. Hemophilia A belongs to the group of hereditary coagulopathies 
stipulated by deficiency of coagulation factor VIII and characterized by bleeding of hematoma like 
type. Genes stipulating development of hemophilia are X-linked; due to it the disease runs in the 
family by recessive inheritance through female lineage. Combination of these two diseases is rather 
rare that requires cardiosurgeons’ apprehensive attitude [1]. 
Tetralogy of Fallot (TOF) is the complex anatomical anomaly of the heart stipulated by 
undevelopment of the right ventricle infundibulum. There are four components of this malformation in 
the typical case: stenosis of pulmonary artery, non-restrictive ventricular septum defect (VSD), 
dextraposition of the aorta and hypertrophy of the right ventricle. Perimembraneous VSD is detected 
in great majority of the patients but subaortal or supracristal localization of the defect is possible. TOF 
may be combined with other cardiac malformations: right sided arch of the aorta (20-25%), vascular 
ring, secondary atrial septal defect (ASD), patent ductus ateriosus (PDA), patent common 
atrioventricular canal, persistent left superior vena cava, and partial drainage of pulmonary veins. 
Presence of the second muscular VSD is possible in 3-4% cases. Combination of cardiac 
malformations and hemophilia is reported in literature [5, 7]. 
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Aim. To review our experience of the surgical treatment of child with TOF and Hemophilia A, the 
importance of timely and detailed diagnostics for the optimization surgical and therapeutic approach. 
Material and Methods. Retrospective analysis of clinical case of combination of TOF and Hemophilia 
Ain a child operated in ST “Zaycev V.T. Institute of General and Urgent Surgery AMS of Ukraine”. 
Clinical case. A boy of 8 months old was admitted to the department of cardiosurgery and 
emergency cardiology from the regional cardiologic center of Kharkov regional clinical children’s 
hospital with the diagnosis: Congenital heart disease, TOF. On admission parents complained of 
perioral cyanosis during agitation and appearance of dense subcutaneous masses with small 
ecchymoses on their surface. Congenital heart disease was diagnosed immediately after birth. The 
child stays under supervision of cardiologist. 
Anamnesis vitae: The child is from 4th normal pregnancy, 2nd physiological delivery; gestational 
age was 39 weeks. He was not vaccinated. On the 1st month the child was hospitalized to the municipal 
perinatal center with the diagnosis: Congenital heart disease, TOF, perinatal affection of CNS, syndrome of 
increased irritability, syndrome of dystonia, conjugative jaundice, protracted course. 
Objective status on admission: child’s condition was moderate concerning main and accessory 
diseases. He was conscious. Psychomotor development corresponded to age. Skin and mucous 
membranes were of usual color; single ecchymoses of 0.4 cm in diameter localized above 
subcutaneous induration were present on the right shank and on the anterior surface of the chest. The 
same ecchymoses used to appear during child’s staying at a hospital. On percussion pulmonary sound 
was heard above lungs, on auscultation rough respiration was heard. Borders of relative heart dullness 
were enlarged 1.0 cm to the right. On palpation systolic thrill was detected in II-III intercostal spaces 
near the sternum border. On auscultation cardiac tones were rhythmic; rough systolic murmur was 
heard in all points of auscultation. Second tone above pulmonary artery was weak. CR was 124 bpm, 
BP was 85/50 mm Hg, SpO2 – 96%. The abdomen was soft, palpable in all regions. Liver’s edge was 
2 cm below the ribs arch; spleen was impalpable. Bowel and bladder functions were within normal. 
X-ray of the chest. Increased transparency of pulmonary pattern was detected. The heart in the 
frontal view had typical shape of “coeur en sabot”. Second arch along left contour was markedly 
smoothed. Length of the heart was slightly increased, the apex is rounded, “blunt”, lifted upwards and 
localized high above diaphragm. 
ECG. Right axis deviation, high and sharpened wave P, and signs of right ventricle 
hypertrophy were detected. 
Echo-CG. VSD with left to right shunt with minimal gradient on the defect of 1.2 cm in 
diameter is detected. Dextraposition of aorta is 50%. Moderate infundibular stenosis of pulmonary 
artery with gradient 32 mm Hg is present. PDA is functioning. 
EDD – 2.8 cm, ESD – 1.7 cm, RV – 1.7 cm, RA – 1.9 cm, LA – 2.4 cm. Blood flow in 
abdominal aorta is of pulsatile character. Arch of aorta is localized typically. Valves are unremarkable.  
The child was examined in hematological department of Kharkov Municipal Clinical Children’s 
Hospital №16. Common blood count was unremarkable. Blood clotting time: beginning at 5'20'', end at 
5’47”. Duration of bleeding – 1’39”. Functional liver test: ALT – 1.1 mmol/l, ALP – 3.9 U, thymol test – 
2.5 U, total bilirubin – 20.9 μmol/l, direct bilirubin – 5.9 μmol/l, indirect bilirubin – 15.0 μmol/l.  
Proteinogram: total protein – 64 g/l, albumin – 71.5%, globulins: α1 – 2.8%, α2 – 8.3%, β –
7.0%, γ – 10.4%. 
Autocoagulation test: А <1%, Т1 – 12 min, Т2 – 20 min, МА – 85%, F – 50, inactivation 
index of thromboplastin – 2.4, fibrinogen – 2.2 g/l, prothrombin time – 83%.  
Activity of factor VIII– 0.0%, activity of factor IX – 27.5%. 
The following diagnosis was made: Hemophilia A, severe form. 
Taking into account indications for operation, complete support with blood preparations 
according to hematologists recommendations, it was decided to operate the child under 
cardiopulmonary bypass. 
Plastics of the defect of ventricular septum with baffle patch Gore-tex, PDA ligation, excision 
of infundibular stenosis on the background of factor VII injection at the rate of 50 U/kg every 8 hours 
as preoperative preparation during 3 days and during 6 days after operation. 
Results. Surgical treatment was successful without significant bleeding. Postoperative course 
was unremarkable. The child was discharged from the hospital on the 10th day after operation in 
satisfactory condition under supervision of cardiologist and hematologist. 
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Discussion. Congenital heart disease is formed during intrauterine period but, as a rule, they 
are not hereditary. According to medical statistics, probability of congenital heart disease development 
as related to total population is 1:100 healthy children. TOF is one of the most wide spread cyanotic 
congenital heart disease [6]. It is diagnosed in 10-30% of infants suffering from congenital heart 
disease. French pathologist Fallot described this pathology as nosological entity for the first time in 
1888 year. Pathological manifestations vary because each of the anatomical signs can have different 
form and intensity. Absence of cyanosis in this child can be explained by functioning of PDA via 
which blood passed from aorta to lungs and compensated lack of blood flow of lesser circulation. 
Treatment of this pathology is surgical. Specific prophylaxis is not worked out. 
Hemophilia A is a disease from the group of hereditary coagulopathies stipulated by deficiency of 
coagulation factor VIII and characterized by bleeding of hematoma like type. Genes stipulating 
development of hemophilia are X-linked; due to it the disease runs in the family by recessive inheritance 
through female lineage. Hemophilia can manifest in whatever age. Disease manifests with bleeding of 
various localization, appearance of painful intermuscular hematomas and hemarthroses. 
Decreased consumption of prothrombin, delayed recalcification time, delayed blood clotting 
time (capillary and venous), decreased quantity of factor VIII, and disorders of thromboplastin 
formation are detected in laboratory tests. Replacement therapy is the main principle of hemophilia’s 
treatment. Nowadays is it performed with the help of intravenous infusions of concentrated 
preparations of factor VIII which allow achieving hemostatic factor’s level [8]. 
Calculation of the dose of concentrated factor VIII: 
Dose (IU) = body weight x (required activity – basal activity). 
Presently purified factors are used in which both enveloped (HIV, viruses of hepatitis B and C), 
and non-enveloped (virus of hepatitis A, parvovirus) viruses are extracted. Methods of genetic treatment 
are under development [3]. Coagulation factors VIIa (NovoSeven) and VIII (Kogenate) are successfully 
used. Possibility of getting of transgenic cow’s milk enriched with factor VIII is reported [4]. 
Genetic counselling of marrying persons is the most important measure. Rather often families 
having a child suffering from hemophilia are in need of comprehensive assistance for resolving 
problems of the whole family [8]. 
On retrospective investigation of frequency of hemophilia and congenital heart pathology 
combination, as well as X-linked diseases, one case of CHD upon 134 patients with hemophilia was 
found, giving frequency 0.75% in comparison with 0.8% in general population at birth. In this 
research significant difference in frequency of combination of CHD with hemophilia A and B in 
comparison with data in general population or significant difference between relatives of patients 
suffering from hemophilia in comparison with control group has not been found [2]. 
Conclusions. Surgical treatment has been and remains the method of choice in TOF. The 
closest and long-term prognosis for patients operated with TOF are usually favorable. Timely and 
complete diagnosis of comorbidities and specific preparation for the intervention allows to perform 
surgery safely even in case of Hemophilia A. 
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